Results 281 to 290 of about 2,902,189 (362)

Intranasal Drug Administration for Psychomotor Agitation as a Safe and Effective Prehospital Intervention: An Integrative Review. [PDF]

Nurs Rep
Burgos-Esteban A, Cordón-Hurtado V, Giménez-Luzuriaga M, Peinado-Quesada M, Gómez-Lage L, Juárez-Vela R, Czapla M, García-Criado J, Navas-Echazarreta N, Rodríguez-Calvo A, Lasa-Berasain P, Quintana-Diaz M.   +11 more
europepmc   +1 more source

Persistent Leukoencephalopathy Following H1N1 Infection Associated With a Novel MYRF Variant (p.Gly735Asp)

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Mutations in myelin regulatory factor (MYRF) are linked to demyelinating disorders. We report a 38‐year‐old male who developed acute symmetric leukoencephalopathy mimicking a stroke following an influenza A virus infection. While clinical symptoms markedly improved with corticosteroids, MRI revealed persistent white matter lesions, contrasting
Jinghan Hu, Leiyun Huang, Wan Zhu, Min Peng, Qiang Gong, Jing Qian   +5 more
wiley   +1 more source

Integrating social and behavior change communication into mass drug administration campaigns for neglected tropical diseases: insights and best practices from Jimma, Ethiopia. [PDF]

Front Public Health
Birhanu Z, Sudhakar M, Abdissa D, Abraham G, Bulcha G, Shiferaw T, Berhanu N, Teshome F, Miecha H, Kebede Y.   +9 more
europepmc   +1 more source

Memorandum from Arthur Hull Hayes Jr., Food and Drug Administration to C. Everett Koop

, 1983
Arthur H. Hayes
openalex   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Sequential intravesical Bacillus Calmette-Güerin and mitomycin C applied with electromotive drug administration therapy for non-muscle invasive bladder cancer. [PDF]

Front Oncol
Bakula M, Hudolin T, Kulis T, Zekulic T, Andelic J, Zimak Z, Cikic B, Juric I, Kastelan Z.   +8 more
europepmc   +1 more source

Lessons from piloting and scaling a real-time DHIS2 based treatment reporting tool for mass drug administration in Nigeria. [PDF]

PLoS Negl Trop Dis
Imhansoloeva M, Nwosu C, Osinoiki O, Isiyaku S, Anyaike C, Amodu-Agbi P, Egbelu U, Nwoye A, Oyinloye P, Abdurahman AU, Otiji I, Nweke L, Kumbur J, Ishaya R, Dixon R, Bartlett S.   +15 more
europepmc   +1 more source

Engineering human protein switches for functional control of CARs and transcription factors via oral drug administration

Sylvander E, Muñoz-López Á, D’Accardio G, Emminger D, Mouratidis K, Engert F, Baik H, Balaji S, Michls T, Buri MC, Maresch D, Urbanetz A, Schäfer M, Mittelstaet J, Zuber J, Rosato A, Engels B, Zajc CU, Traxlmayr MW, Lehner M.   +19 more
europepmc   +1 more source

The cost of mass drug administration for trachoma in two counties of the Republic of South Sudan

Tim Jesudason, Angelia M. Sanders, Stephen Ohidor, Alexis S. Delahunt, Andrew R. Deathe, Lochebe Boniface, Isaiah Buot, Mekete Bikis, Samual Makoy, Yak Yak Bol, James Niquette, E. Kelly Callahan, Damian Walker, Scott D. Nash   +13 more
openalex   +2 more sources

Drug-Induced Intestinal Angioedema: A Disproportionality Analysis Using the United States Food and Drug Administration Adverse Event Reporting System Database and Literature Review. [PDF]

Med Sci (Basel)
Bharathi Rajaduraivelpandian P, Rao RR, Kamath A.   +2 more
europepmc   +1 more source